Reagent testing for allergic reaction detection/management for medical treatment facility
Ended Awarded Last action
- Contract number
- HT009026FG0130008
- Awardee
-
Phadia US Inc. UEI DK4EVCWUNUM4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $79,572
Award facts
- Contract value 100% obligated
- $79,572.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 5680 Miscellaneous Construction Materials
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 4 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Portage, MI 49002, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $79,572.42 firm fixed-price Blanket Purchase Agreement (BPA) call to Phadia US Inc.'s Immunodiagnostics Division on January 21, 2026, for reagent testing supplies to support allergic reaction detection and management at a military medical treatment facility in Portage, Michigan. The contract is scheduled for completion by September 30, 2026, and was awarded through open market procurement without set-aside designation. Phadia US Inc., a foreign-owned subsidiary of Thermo Fisher Scientific, specializes in advanced allergy and autoimmune diagnostic testing solutions and has established itself as a critical provider of immunodiagnostic equipment and reagents to federal healthcare agencies.
This BPA call leverages Phadia's existing indefinite delivery/indefinite quantity contract vehicles and demonstrates the company's strategic role in supporting military medical diagnostic capabilities. The award reflects the Defense Health Agency's continued reliance on Phadia's specialized allergen-specific immunoglobulin E (IgE) antibody testing reagents and equipment, which enable rapid and accurate allergy diagnosis and management across military medical facilities. The firm fixed-price structure ensures cost predictability while allowing the government flexibility to order reagent supplies as needed through the BPA mechanism.
Quick answers
Who was awarded contract HT009026FG0130008?
HT009026FG0130008 was awarded to Phadia US Inc. by Defense Health Agency (Department of Defense) on January 21, 2026.
How much is contract HT009026FG0130008 worth?
The government has obligated $79,572 on HT009026FG0130008.
Is contract HT009026FG0130008 an order under another contract?
Yes. HT009026FG0130008 is a BPA call under FA301624A0046, a blanket purchase agreement.
Was contract HT009026FG0130008 competed?
The extent of competition for HT009026FG0130008 was competed under sap. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award